Skip to main content
Medical information Clinical review pending

Genetic Testing

EPHX2 Gene Hypercholesterolemia Familial Due to LDLR Defect Modifier of Genetic Test

Genetic test for the EPHX2 gene to understand familial hypercholesterolemia linked to LDL receptor defects. Helps assess cholesterol metabolism and cardiovascular risk.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample, extracted DNA, or one drop of blood on an FTA card.
Results
Approximately 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. A clinical history and genetic counseling session to create a pedigree chart of affected family members are recommended prior to testing.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the EPHX2 Gene Hypercholesterolemia Familial Due to LDLR Defect Modifier of Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of hypercholesterolemia
  • ✓High cholesterol levels despite lifestyle changes
  • ✓Early onset cardiovascular disease
  • ✓Family members diagnosed with familial hypercholesterolemia
  • ✓Understanding genetic predisposition to high cholesterol
02

In plain language

What this test helps you understand

This test helps identify genetic factors contributing to familial hypercholesterolemia, aiding in risk assessment, personalized management strategies, and family counseling regarding cholesterol metabolism and cardiovascular health.
The EPHX2 Gene Hypercholesterolemia test is a genetic assessment designed to identify variations in the EPHX2 gene that may contribute to familial hypercholesterolemia, particularly when associated with LDL receptor defects. This test uses Next Generation Sequencing (NGS) technology to analyze your DNA for specific genetic modifications. Understanding these modifications can provide valuable insights into your predisposition to high cholesterol levels and related metabolic disorders. This information can help healthcare providers tailor management strategies and assess your risk for cardiovascular diseases.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. A clinical history and genetic counseling session to create a pedigree chart of affected family members are recommended prior to testing.
SampleBlood sample, extracted DNA, or one drop of blood on an FTA card.
MethodologyNext Generation Sequencing (NGS) of the EPHX2 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the EPHX2 gene. Other genes or factors may also contribute to hypercholesterolemia. Results should be interpreted in conjunction with clinical findings and family history. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Familial hypercholesterolemia is a genetic disorder characterized by very high levels of low-density lipoprotein (LDL) cholesterol, often leading to early-onset cardiovascular disease.
The EPHX2 gene provides instructions for making an enzyme involved in metabolism. Variations in this gene can influence cholesterol levels and LDL receptor function.
Individuals with a family history of high cholesterol, early heart disease, or diagnosed familial hypercholesterolemia may benefit from this test.
Results will indicate the presence or absence of specific genetic variations in the EPHX2 gene. A healthcare provider or genetic counselor can help interpret the results in the context of your personal and family health history.
Yes, genetic counseling before and after testing is highly recommended to understand the test's implications, interpret results, and discuss potential risks for family members.
Insurance coverage for genetic testing varies. Please check with your insurance provider regarding coverage for this specific test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp